Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Praziquantel; Pyrantel embonate ; Febantel
Chanelle Pharmaceuticals Manufacturing Limited
QP52AA51
Praziquantel; Pyrantel embonate ; Febantel
175,504,525 mg/tablet
Tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
Dogs
praziquantel, combinations
Endoparasiticide
Authorised
2012-03-02
1 _ _1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cazitel Plus XL Tablets For Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCES: Praziquantel 175 mg Pyrantel Embonate 504 mg (equivalent to 175 mg pyrantel) Febantel 525 mg EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS Lactose monohydrate, Microcrystalline cellulose, Magnesium stearate, Colloidal anhydrous silica, Croscarmellose sodium, Sodium laurilsulfate Pork flavour A yellow coloured oblong tablet with a breakline on both sides The tablets can be divided into two equal parts. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Dogs. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES In adult dogs: Treatment of mixed infections by nematodes and cestodes of the following species NEMATODES: ASCARIDS: _Toxocara canis_ , _Toxascaris leonina_ (adult and late immature forms). HOOKWORMS: _Uncinaria stenocephala_ , _Ancylostoma caninum_ (adults). WHIPWORMS: _Trichuris vulpis_ (adults). CESTODES: TAPEWORMS: _Echinococcus_ species, _(E. granulosus, E. multilocularis), Taenia_ species, _(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum_ (adult and immature forms). 3.3 CONTRAINDICATIONS Do not use simultaneously with piperazine compounds. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. 3.4 SPECIAL WARNINGS Fleas serve as intermediate hosts for one common type of tapeworm – _Dipylidium caninum._ 2 Tapeworm infestation is certain to reoccur unless control of intermediate hosts such as fleas, mice, etc. is undertaken. Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: • Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. • Underdosing, which may be due to underestimation of body weight, misadministration of the product. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the targe Leggi il documento completo